Michael Weiswasser
About Michael Weiswasser
Michael Weiswasser is the Clinical Scientist Program Lead for Rheumatology at Bristol Myers Squibb, with over 20 years of experience in clinical research and pharmaceutical development.
Current Role at Bristol Myers Squibb
Michael Weiswasser currently serves as the Clinical Scientist Program Lead, Rheumatology at Bristol Myers Squibb. He joined the company in March 2020 and brings over 20 years of experience in clinical research and pharmaceutical development to his role. His responsibilities include leading clinical research programs in the field of rheumatology.
Previous Experience at Celgene
Michael Weiswasser spent 13 years at Celgene, where he held multiple roles. He started as a Clinical Research Scientist from 2007 to 2010. He was promoted to Senior Clinical Research Scientist from 2010 to 2016. Finally, he served as Principal Clinical Research Scientist from 2016 to 2020. His extensive experience at Celgene provided him with a solid foundation in clinical research and project leadership.
Education Background
Michael Weiswasser holds a Master of Public Health (MPH) from Yale University School of Epidemiology/Public Health, specializing in healthcare management, completed between 1998 and 2000. He also earned a Bachelor of Arts (BA) in Zoology/Animal Biology from Connecticut College, graduating in 1994. His academic background underpins his expertise in epidemiology, public health, and healthcare management.
Roles at Nycomed and Pfizer
At Nycomed, Michael Weiswasser served as a Senior Clinical Research Scientist from 2004 to 2007, focusing on clinical research. Prior to that, he worked as an Outcomes Research Scientist at Pfizer from 2002 to 2004, where he gained valuable experience in outcomes research in the R&D division located in Groton/New London.
Early Career as Business Strategy Consultant
Michael Weiswasser began his career as a business strategy consultant at the Institutes for Pharmaceutical Discovery from 2000 to 2001. This role allowed him to apply his knowledge in healthcare management and public health early on, setting a strong foundation for his subsequent roles in clinical research and development in the pharmaceutical industry.